If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.40    -4.40 (-1.26%)
Bid:
345.80
Ask:
346.20
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Directorate change

13 May 2026 16:12

RNS Number : 2188E
TP ICAP Group plc
13 May 2026
 

 

TP ICAP Group plc

LEI: 2138006YAA7IRVKKGE63

13 May 2026

 

TP ICAP Group plc (the 'Company' or 'TP ICAP')

 

Director Changes

 

The Company is pleased to announce the appointment of Jane Guyett and Paul Newman as Independent Non-executive Directors of the Company. Jane's appointment will be effective from 1 July 2026 and Paul's appointment effective from 1 August 2026. On joining the Board Jane will assume the role of Chair of the Remuneration Committee and join the Audit Committee. Paul will join the Risk Committee and be the EMEA Workforce Engagement Director. Both Jane and Paul will join the Nominations & Governance Committee.

 

Jane is currently the Senior Independent Director at Hiscox Group, a Non-Executive Director at Royal London Mutual Insurance Society ('Royal London') and BDO LLP. She Chairs the Remuneration Committees for Hiscox and Royal London and the Risk Oversight Committee at BDO. The majority of Jane's executive career was spent at Bank of America, where she served in leadership roles including COO for Global Markets EMEA & Asia.

 

Paul brings over 40 years of experience in capital markets, wholesale broking, and commodity derivatives. He spent more than 25 years at ICAP plc, where he founded the firm's commodities arm in 1990 and served as Executive Managing Director, and subsequently Chair of ICAP Energy until 2016, and as Chair of ICAP Shipping from 2008 to 2014. He was a director at NEX Group plc from 2016 until its acquisition by CME Group in 2018.

Commenting on Jane and Paul's appointments, Richard Berliand, Chair of TP ICAP Group plc, said:

 

"We are very pleased to welcome both Jane and Paul to the Board of the Company. They both bring substantial capital markets, broking and securities experience from their respective executive career and directorship roles, and each will be a great addition to our Board."

 

The Company also announces that Tracy Clarke and Mark Hemsley, Independent Non-executive Directors, will stand down as Directors of the Company with effect from 30 June 2026. Commenting on their future departure, Richard Berliand, said:

 

"The Board would like to thank both Tracy and Mark for their significant contribution to the Board during their tenure. The insights, challenge, and advice that they have been able to bring to the debate is much appreciated".

 

This announcement is made in accordance with UK Listing Rules 6.4.8R and there are no other additional matters that require disclosure under Listing Rule 6.4.6.

 

 

 

ENDS

 

For further information, please contact:

 

Victoria Hames

Company Secretariat

Email: CompanySecretarial@tpicap.com

 

Derek Brown

Head of Investor RelationsDirect: +44 (0) 20 3933 0447

Email: Derek.brown@tpicap.com

 

Richard Newman

Group Head of Marketing and Communications

Direct: +44 (0) 7469 039 307

Email: Richard.Newman@tpicap.com

 

About TP ICAP Group plc

 

TP ICAP connects buyers and sellers in global financial, energy and commodities markets.

We are the world's leading wholesale market intermediary, with a portfolio of businesses that provide broking services, data & analytics and market intelligence, trusted by clients around the world.

We operate from more than 60 offices across 28 countries, supporting brokers with award-winning and market-leading technology.

 

Further information on the company and its activities is available on the Company's website:

www.tpicap.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEXLFFQELFBBB
Date   Source Headline
5th Apr 20183:13 pmRNSAnnual Financial Report
29th Mar 20187:00 amRNSTotal Voting Rights
26th Mar 20181:26 pmRNSAllotment of consideration shares
26th Mar 201811:01 amRNSDirector/PDMR Shareholding
14th Mar 20185:19 pmRNSDirector/PDMR Shareholding
13th Mar 20187:00 amRNSFinal Results
8th Jan 20187:00 amRNSAcquisition
5th Jan 20181:24 pmRNSTotal Voting Rights
5th Jan 20187:00 amRNSNotice of Results
15th Dec 20177:00 amRNSDirector/PDMR Shareholding
8th Dec 201712:52 pmRNSHolding(s) in Company
8th Dec 20177:00 amRNSDirectorate Change
30th Nov 20177:00 amRNSAcquisition of Coex Partners Limited
30th Nov 20177:00 amRNSCapital Markets Update
29th Nov 20173:45 pmRNSDirector/PDMR Shareholding
23rd Nov 20174:26 pmRNSHolding(s) in Company
22nd Nov 201711:54 amRNSHolding(s) in Company
3rd Nov 20177:00 amRNS3rd Quarter Trading Update
17th Oct 20177:00 amRNSDirectorate Change
5th Oct 20179:58 amRNSHolding(s) in Company
29th Sep 20178:21 amRNSHolding(s) in Company
22nd Sep 20173:58 pmRNSHolding(s) in Company
22nd Sep 201712:28 pmRNSHolding(s) in Company
30th Aug 20173:33 pmRNSHolding(s) in Company
8th Aug 20177:00 amRNSFinancial and Interim Management Report
17th Jul 201710:33 amRNSHolding(s) in Company
14th Jul 201712:38 pmRNSHolding(s) in Company
22nd Jun 20179:53 amRNSHolding(s) in Company
16th Jun 201711:37 amRNSHolding(s) in Company
22nd May 20173:02 pmRNSDirector/PDMR Shareholding
15th May 20172:52 pmRNSDirector/PDMR Shareholding
11th May 20174:45 pmRNSResult of Annual General Meeting
11th May 20177:02 amRNSBalance Sheet Strengthens with £270m Bulk Annuity
11th May 20177:00 amRNSAGM Statement and Trading Update
6th Apr 201711:00 amRNSAnnual Financial Report
5th Apr 201711:57 amRNSDirector/PDMR Shareholding
27th Mar 20174:41 pmRNSDirector/PDMR Shareholding
14th Mar 20177:00 amRNSFinal Results
28th Feb 201712:27 pmRNSNotice of Results
21st Feb 20179:29 amRNSHolding(s) in Company
24th Jan 20176:04 pmRNSTP ICAP GBP 7yr - Post-Stabilisation Notice
24th Jan 20174:42 pmRNSPublication of Final Terms
19th Jan 20175:29 pmRNSIssue of £500m Fixed Rate Senior Unsecured Notes
19th Jan 20178:39 amRNSTP ICAP GBP 7yr - Pre-Stabilisation Notice
18th Jan 201711:03 amRNSPublication of a Prospectus
16th Jan 20176:06 pmRNSHolding(s) in Company
12th Jan 20174:47 pmRNSHolding(s) in Company
12th Jan 20174:42 pmRNSHolding(s) in Company
12th Jan 20174:28 pmRNSHolding(s) in Company
10th Jan 201710:12 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.